Gene therapy for focal neocortical epilepsy : optimising viral vectors for clinical translation
Approximately 0.5% of the world’s population suffers from focal epilepsy. While traditional pharmacotherapy provides essential relief for millions of patients, almost half continue to experience uncontrolled seizures. Of these, only a select few are suitable for surgical intervention. There is there...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.747274 |